NAVB

Navidea Biopharmaceuticals Inc.

NAVB

Market cap $7.8M

Delisted

NAVB was delisted on the 5th of October, 2023.

27 hedge funds and large institutions have $392K invested in Navidea Biopharmaceuticals Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 25 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $14K

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

–

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

–

Puts

$14K

Net Calls

Net Calls Change

Top Buyers

1		+$144K
2		+$107K
3		+$37.8K
4	HighTower Advisors Chicago, Illinois	+$25.5K
5	ACM Allred Capital Management Dallas, Texas	+$13.2K

Top Sellers

1		-$38.2K
2		-$19K
3		-$16K
4	Creative Planning Overland Park, Kansas	-$16K
5	UBS Group Zurich, Switzerland	-$12K

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–

Navidea Biopharmaceuticals Inc. NAVB Market cap $7.8M